Ignite Creation Date:
2024-05-06 @ 9:12 AM
Last Modification Date:
2024-10-26 @ 12:11 PM
Study NCT ID:
NCT02926586
Status:
COMPLETED
Last Update Posted:
2022-05-11
First Post:
2016-10-05
Brief Title:
Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML
Sponsor:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine
Organization:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine
Organization Data
Organization:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine
Class:
OTHER
Study ID:
CBF-AML-2016
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine
Lead Sponsor Class:
OTHER
Responsible Party:
Xianmin Song MD
Responsible Party Title:
professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine
Old Name:
None
Old Organization:
None